Mohamad Abdel-Aziz (Mohamed Abdel-Aziz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Histone Deacetylase

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie 357 (5) (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie 357 (5) (2024)
Esraa Mahmoud, Dalia Abdelhamid, Bahaa G M Youssif, Hesham A M Gomaa, Alaa M Hayallah, Mohamad Abdel-Aziz
Design, synthesis, and antiproliferative activity of new indole/1,2,4-triazole/chalcone hybrids as EGFR and/or c-MET inhibitors. Archiv der Pharmazie 357 (9) (2024)
Mostafa M Badran, Samar H Abbas, Mikako Fujita, Mohamad Abdel-Aziz
Harnessing pyrimidine as a building block for histone deacetylase inhibitors. Archiv der Pharmazie (2023)
Hesham A Abou-Zied, Eman A M Beshr, Hesham A M Gomaa, Yaser A Mostafa, Bahaa G M Youssif, Alaa M Hayallah, Mohamad Abdel-Aziz
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF V600E with promising antiproliferative properties. Archiv der Pharmazie (2022)